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Abstract: Type 2 diabetes mellitus (T2DM) is associated with an increase of premature 
appearance of several disorders such as cardiac complications. Thus, we test the 
hypothesis that a combination of a high fat diet (HFD) and low doses of streptozotocin 
(STZ) recapitulate a suitable mice model of T2DM to study the cardiac mitochondrial 
disturbances induced by this disease. Animals were divided in 2 groups: the T2DM group 
was given a HFD and injected with 2 low doses of STZ, while the CNTRL group was given 
a standard chow and a buffer solution. The combination of HFD and STZ recapitulate 
the T2DM metabolic profile showing higher blood glucose levels in T2DM mice when 
compared to CNTRL, and also, insulin resistance. The kidney structure/function was 
preserved. Regarding cardiac mitochondrial function, in all phosphorylative states, the 
cardiac mitochondria from T2DM mice presented reduced oxygen fluxes when compared 
to CNTRL mice. Also, mitochondria from T2DM mice showed decreased citrate synthase 
activity and lower protein content of mitochondrial complexes. Our results show that 
in this non-obese T2DM model, which recapitulates the classical metabolic alterations, 
mitochondrial function is impaired and provides a useful model to deepen study the 
mechanisms underlying these alterations.
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INTRODUCTION
The prevalence and incidence of diabetes 
mellitus (DM) is increasing worldwide. Nowadays, 
the International Diabetes Federation calculates 
that there are more than 425 million people with 
diabetes and it is estimated that by the year 
2045, approximately 629 million people will have 
diabetes (IDF 2017). 
Type 2 diabetes mellitus (T2DM) is the most 
prevalent form of diabetes and about 90% of 
diabetic patients develop this syndrome, which 
is characterized by sustained high blood glucose 
levels and insulin resistance (Kaiser et al. 2018). 
This syndrome can lead to cardiovascular 
complications such as hypertension, coronary 
disease and stroke (Zimmet et al. 2001). Despite 
the advances in the treatment of this syndrome, 
there is still no effective treatment without 
secondary effects and this makes necessary to 
develop new strategies. For this, development 
of better animal T2DM models, which accurately 
reflect the pathogenesis of the human syndrome, 
are needed.
There exist several experimental T2DM 
models, of which rodents are the best choice 
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because of their short generation time. These 
models can be classified in spontaneous 
or genetic models and in induced models 
(Chatzigeorgiou et al. 2009, Srinivasan & 
Ramarao 2007). The spontaneous models are 
those bloodlines that remain relatively unaltered 
through inbred crosses that come either from an 
animal or from a series of selective crossings 
from an animal, where spontaneous diabetes 
has been detected or also, from a series 
of selective crossings promoting a certain 
phenotypic feature of human T2DM. Examples 
of these spontaneous T2DM mice models are 
the New Zeland Obese mouse (NZO), the db/
db mouse or the ob/ob mouse among others. 
In contrast, the induced models are those in 
which T2DM is induced by chemicals (as alloxan 
or streptozotocin) or dietary manipulation, 
or by a combination of both (Srinivasan et al. 
2005, Rees & Alcolado 2005). Even though this 
wide variety of animal models, most of them 
do not simulate accurately the human T2DM 
natural clinical history, besides being not easily 
achieved or affordable. 
In the last decade, a model which combines 
a high fat diet (HFD) with low doses of a 
pancreatic β-cell toxin streptozotocin (STZ), has 
emerged as the best new alternative model that 
mimics the natural history of the progression 
of T2DM (Srinivasan & Ramarao 2007, Reed et 
al. 2000). The administration of HFD results in 
an insulin resistance situation, which is a key 
characteristic of T2DM. In addition, the low dose 
of STZ produces a partial β-cell dysfunction 
causing mild insulin secretion impairment. Thus, 
the combination of these two elements leads to 
a T2DM condition in experimental animals which 
is very close to the human one, even though 
in a shorter period of time. In addition, these 
models reflect the metabolic characteristics 
of human T2DM such as abnormalities in lipid 
metabolism (Chatzigeorgiou et al. 2009, Reed et 
al. 2000, Li et al. 2015). 
It is well known that approximately 65-70% 
of diabetic patients die due to cardiac alterations 
(Casis & Echevarria 2004, Laakso 2001, De Rosa 
et al. 2018). Mitochondrial dysfunction is the 
one of most related hypotheses of the cardiac 
dysfunction in diabetic individuals. Mitochondria 
represent around 30% of myocardial volume 
density (Schaper et al. 1985) and are responsible 
for generating about 60-90% of necessary 
energy for cardiomyocytes under form of high 
energy phosphoanhydride bonds in ATP and 
phosphagen by the fatty acid oxidation (Saddik 
et al. 1993). Thus, the metabolic imbalance 
induced by diabetes can cause mitochondrial 
dysfunction leading to early appearance of other 
cardiac alterations, and represent an important 
function to be evaluated in order to understand 
the molecular basis of the diabetic disease. In 
fact, previous observations in human hearts from 
T2DM patients presented decreased respiration 
rate in subsarcolemmal mitochondria (Croston 
et al. 2014). In a mouse model of T2DM a similar 
observation was detected (Koncsos et al. 2016). 
Nevertheless, in the present study we extended 
these evaluations including hydrogen peroxide 
(H2O2) release measurements and normalizing 
these data by specific mitochondrial content 
marker in our T2DM model.
Thus, the present work aims to test the 
hypothesis that a combination of HDF and two 
low doses of STZ recapitulate the natural history 
of the metabolic profile of T2DM, as well as the 
mitochondrial dysfunction. This model emerges 
as a new tool to study the early mechanisms 
underlying the cardiac alterations in non-
obese T2DM as well as to test a new therapeutic 
approach.
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MATERIALS AND METHODS
Animals and experimental protocol
All animal experiments were performed on 
adult C57BL/6 male mice in accordance with 
the Guide for the Care and Use of Laboratory 
Animals and approved by the Committee of the 
Federal University of Rio de Janeiro (protocol 
number 170/18). Animals were kept in controlled 
conditions of constant temperature (23 °C) and 
standard 12 h/12 h light/dark cycle with free 
access to water and chow. 
Animals were divided in 2 groups: control 
non-diabetic mice (CNTRL) and type 2 diabetic 
mice (T2DM). CNTRL mice received a standard 
chow (Nuvilab, Brasil) consisting of 12% fat, 67% 
carbohydrate and 21% protein, with total calorific 
value of 3.33 Kcal/g. The T2DM mice group received 
a high fat diet (Pragsoluções Biociências, Jaú, SP, 
Brasil) consisting of 45% fat, 35% carbohydrates 
and 20% protein, with total calorific value of 4.73 
Kcal/g. Two weeks after dietary establishment, 
T2DM mice received 2 consecutive injections 
of STZ (40 mg/kg/i.p.) (Sigma-Aldrich, St. Louis, 
MO, USA) diluted in 0.05 M citrate buffer (pH 4.5) 
separated 24 h, while CNTRL mice were given 
a vehicle (citrate buffer i.p.). Four weeks after 
injections biometric, functional, biochemical and 
molecular parameters were measured (Figure 
1a). T2DM mice with the fasting blood glucose 
(FBG) higher than 140 mg/dl were considered 
diabetic. Both diets were maintained during the 
whole procedure for a total time of 6 weeks.  
Fasting blood glucose, insulin, triglycerides 
and cholesterol concentration
FBG levels were measured using an automated 
glucometer (Contour™ TS Bayer HealthCare LLC, 
Mishawaka, IN, USA) with glucose reagent strips 
(Bayer HealthCare LLC). Animals were fasted for 
6 h and blood was obtained from the tip of the 
tail of non-anesthetized mice. Insulin levels 
were measured using a commercial insulin RIA 
kit (ImmunoChem Coated Tube - Insulin – MP 
Biomedicals, Santa Ana, CA, USA) from blood 
serum samples.
Serum triglycerides (TG) and cholesterol 
levels were determined by enzymatic 
colorimetric method using commercial kits 
(Gold Analisa, Belo Horizonte, MG, Brasil).
Intraperitoneal glucose tolerance test, 
intraperitoneal insulin tolerance test and 
insulin resistance
For both, intraperitoneal glucose tolerance test 
(IPGTT) and intraperitoneal insulin tolerance 
test (IPITT), animals were fasted for 6 h and 4 
h respectively. After that, animals were injected 
intraperitoneally 2 g/kg of glucose for IPGTT 
or 0.5 U/kg of insulin for IPITT and FBG was 
measured at different time points (0 (basal), 15, 
30, 60 and 120 min) from a tail snip.
To assess insulin resistance, the HOMA-
IR (homeostasis model assessment of insulin 
resistance) index was calculated as: fasting 
serum glucose x fasting serum insulin/22.5. 
Histology and immunofluorescence 
Kidney frozen sections were first fixed with 
4% paraformaldehyde solution (20 min). After 
that, they were permeabilized with 0.5% triton 
X-100 in PBS, incubated with a blocking solution 
containing 1% glycine and 5% bovine serum 
albumin (BSA), and then with a neutrophil 
gelatinase-associated lipocalin (NGAL) rabbit 
polyclonal antibody (Abcam, Cambridge, MA, USA, 
cat # ab63929, 1:50) overnight. An anti-rabbit IgG 
F(ab’)2 conjugated to Cy3 (Sigma-Aldrich, 1:200) 
was applied onto sections, washed with PBS, 
counterstained with DAPI (1:5000), and mounted 
with fluoromount.
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RNA isolation and quantitative real-time 
polymerase chain reaction (qRT-PCR)
The RNA extraction from renal tissue was 
performed with mirVana RNA isolation kit (Thermo 
Scientific, Waltham, MA, USA) and RNA was 
measured spectrophotometrically (Nanodrop 
ND-1000, Thermo Scientific). mRNA expression 
was assessed using a High Capacity cDNA 
Reverse Transcription Kit (Applied Biosystems, 
Foster City, CA, USA), Power SYBR®Green PCR 
Master Mix (Applied Biosystems) and qRT-PCR 
was performed with a ViiA™ 7 Real-Time PCR 
System (Applied Biosystems). All the sequence-
specific oligonucleotide primers (Supplementary 
Material - Table SI) were obtained from Thermo 
Scientific.
Biochemical analysis of the renal function
Blood urea nitrogen (BUN) and creatinine 
level were measured in plasma samples by 
the colorimetric method according to the 
manufacturer’s protocol (K016, Bioclin, Belo 
Horizonte, Brazil).
Cytokines detection
IL-1β, IL-6 and TNF-α cytokines serum 
concentration was measured by a commercial 
ELISA kit (R&D systems Inc, Minneapolis, MN, 
USA) and results were obtained by a SpectraMax 
M3 equipment (Molecular Devices, San Jose, CA, 
USA).
Mitochondria isolation
Mitochondria isolation from the mice hearts was 
adapted from the protocol described by Affourtit 
et al. (2012) with minor modifications. The hearts 
were rapidly removed and rinsed in ice-cold 
Chappell-Perry (CP) buffer (100 mM KCl, 50 mM 
Tris-HCl, 2 mM EGTA, pH 7.2). Then, the hearts 
were blotted dry, weighed and finely minced 
with razor blades, and washed 4-5 times with CP 
buffer. The rinsed tissue was incubated for 5 min 
with CP buffer supplemented with 0.5% albumin, 
5 mM MgCl2, 1 mM ATP and 125 U/100 ml protease 
type VIII, at proportion 1 ml/100 mg of tissue. The 
minced tissue was homogenized (Ultra-turrax 
homogenizer (IKA®, Campinas, SP, Brasil), low 
setting, 3 s, 3 times) and the homogenate was 
centrifuged at 490 x g for 5 min. The resultant 
supernatant was centrifuged at 10368 x g for 10 
min. The pellet was washed and resuspended 
into ice-cold CP buffer and centrifuged at 10368 
x g for 10 min. 
The final mitochondrial pellet was 
resuspended into 150-200 μl of CP buffer. The 
protein dosage of the isolated mitochondria as 
measured by the method described by Lowry 
et al. (1951). The isolated mitochondria were 
subjected to high resolution respirometry to 
measure the fluxes of oxygen consumption. 
High resolution respirometry
The experiments were performed on the 
high-resolution O2k-respirometer (Oroboros 
Instruments, Innsbruck, Austria, EU) with 
mitochondrial respiration media (MIR05) 
containing 0.5 mM EGTA, 3 mM MgCl2, 60 mM 
K-MES, 20 mM taurine, 10 mM KH2PO4, 20 mM 
HEPES, 110 mM sucrose, 1 g/l fat free BSA; pH 
7.1 at 37 °C. The protocol used to evaluate 
mitochondrial function was adapted from Pesta 
& Gnaiger (2012) and consists on sequential 
addition of multiple substrates and inhibitors: 5 
mM pyruvate, 2.5 mM malate, 10 mM glutamate, 
100 μM adenosine 5’-diphosphate (ADP), 1 mM 
ADP, 10 mM succinate, 0.2 μg/ml oligomycin and 
2 μM antimycin A (Ama).  
The respiratory control ratio (RCR) was 
calculated by the oxygen flux after addition 
of succinate in presence of saturating 
concentrations of ADP, divided by the flux after 
oligomycin addition (satADP/Omy). The oxygen 
flux relative to complex I at phosphorylative 
state (CIp) was calculated by the flux in presence 
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of pyruvate, malate, glutamate and saturating 
ADP subtracting the residual oxygen flux (ROX, 
oxygen consumption not associated with the 
oxidative phosphorylation flux) which is the 
flux of oxygen obtained after the addition 
of Ama, a specific complex III inhibitor of 
mitochondria. The flux relative exclusively 
to complex II at phosphorylative state (CIIp) 
was determined by the respiration stimulated 
by succinate minus the flux in presence of 
saturating ADP and complex I substrates (CIp). 
The maximal oxidative phosphorylation capacity 
of the electron transport system (coupled to ATP 
synthesis -OXPHOS) was acquired subtracting 
the ROX from the flux with CI-linked substrates 
plus succinate and saturating ADP. The non-
specific leak of protons (LEAK) was determined 
by oxygen flux after to oligomycin addition 
minus ROX.
The data were analysed in DatLab 5 software 
(Oroboros Instruments) and expressed in pmol.
mg-1.sec-1.
Mitochondrial hydrogen peroxide release
The mitochondrial hydrogen peroxide (H2O2) 
production was measured by horseradish 
peroxidase/Amplex red coupled system. The 
appearance rate of resorufin at 563/587 nm 
(excitation/emission) was monitored in a 
fluorescence spectrophotometer (Varian Cary 
Eclipse, Agilent Technologies, Santa Clara, CA, 
USA). The assay was performed in 2 mL of MIR05 
supplemented with 5.5 μM Amplex red, 2 U/ml 
peroxidase and 40 U/ml superoxide dismutase 
and 0.03 mg/ml of isolated mitochondrial at 
37 °C. The H2O2 release at non-phosphorylative 
state was measured in presence of the same 
substrate concentrations of complex I and II, as 
mentioned above, for mitochondrial respiration. 
This condition induces a high electron potential 
to the ETS level, facilitating the monovalent 
reduction of oxygen and the production of 
superoxide anion radical. These reactive oxygen 
species are rapidly converted in the H2O2, by 
non-limiting amounts of exogenous addition 
superoxide dismutase (SOD). The data generated 
in arbitrary units of fluorescence were analyzed 
in Origin Pro-8 software (Origin Lab Corporation, 
Northampton, MA, USA) and normalized to pmol 
of H2O2.mg
-1.min-1 from standard calibration 
curves of H2O2 performed in the presence of the 
same amount of isolated mitochondria for each 
experiment.
Citrate synthase activity
The enzyme citrate synthase activity was 
measured, as described previously (Eigentler et al. 
2015). The activity was determined by monitoring 
the reduction of 5,5-dithiobis 2-nitrobenzoic 
acid (DTNB) in a spectrophotometer at 420 nm 
(Victor plate reader, PerkinElmer, Waltham, MA, 
USA).  The assay buffer was composed by 20 
mM Tris-HCl, 0.3 mM DTNB, 2 mM EDTA and 0.3 
mM acetyl-coenzyme A, pH 8.0. The reaction was 
initiated with 5 mM oxaloacetate. The generated 
data were analysed in Origin Pro-8 software 
(Origin Lab Corporation) and were expressed as 
nmol.min−1.mg−1.
Western blotting
Cardiac left ventricle were homogenized in lysis 
buffer (Tris-HCl 50 mM, pH 7.4 + NaCl 150 mM, 
EDTA 1 mM, Triton x-100 1%, Sodium deoxycholate 
100 mM, SDS 1%, Sodium pyrophosphate 10 
mM, NaF 100 mM, Sodium orthovanadate 10 
mM and protease inhibitor cocktail) using 
the Ultra-Turrax T25 basic homogenizer (IKA®) 
at 9500 L/min. Samples were held on ice for 
1 h and subsequently centrifuged at 12000 
x g for 15 min at 4 °C. The supernatant was 
collected for protein dosage with PierceTM BCA 
Protein Assay Kit (Thermo Fisher Scientific, 
Waltham, MA, USA) following manufacturer`s 
instructions. Samples (40 μg of total protein) 
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were resolved in SDS-PAGE 15% and transferred 
to a Polyvinylidene difluoride (PVDF) membrane 
(Bio-Rad, Hercules, CA, USA). After transfer, 
membrane was blocked with 5% nonfat dry milk 
for 2 h and incubated with anti-oxphos (Abcam) 
and anti-vinculin (Sigma-Aldrich), overnight at 4 
°C. Then membrane was washed and incubated 
with HRP-conjugated specific secondary 
antibody (Invitrogen, Carlsbad, CA, USA) for 1 h 
at room temperature. Finally, membrane was 
developed using Amersham ECL Prime Western 
Blotting Detection Reagent (GE Healthcare Life 
Sciences, Pittsburgh, PA, USA). The capture of 
chemiluminescent signal was obtained using 
a Imagequant LAS4000 (GE Healthcare Life 
Sciences) equipment. 
Statistical analysis
Data are presented as mean ± SEM. Comparison 
between 2 groups was analyzed by unpaired 
Student’s t-test and multiple comparisons 
were performed using the analysis of two-way 
variance ANOVA and values of p < 0.05 were 
considered statistically significant. Samples 
sizes were estimated on the basis of sample 
availability and previous experimental studies 
of the cardiovascular system (Ferreiro et al. 
2012, Monnerat et al. 2016). All analysis were 
performed using GraphPad Prism 7.0 (GraphPad 
Software, San Diego, CA, USA) and OriginPro8 
(Origin Lab Corporation) softwares. 
RESULTS
HFD and two low doses STZ recapitulate the 
T2DM metabolic profile
At the time, experimental T2DM models that 
try to reproduce the human diabetic cardiac 
alterations have several limitations that do not 
allow taking clear conclusions. 
Six weeks after dietary establishment and 
STZ injection, animals with FBG higher than 140 
mg/dl were considered diabetic and were used 
for the study (Figure 1b). Those T2DM animals 
showed similar serum insulin concentration to 
CNTRL group mice (Figure 1c). Even though T2DM 
mice were fed with a HFD, no exacerbated body 
weight gain was observed (Figure 1d). However, 
the slightly but significant higher body weight on 
T2DM mice when compared to CNTRL group was 
observed. This difference could be explained, at 
least in part, by the higher retroperitoneal and 
epididymal fat tissue measured on T2DM when 
compared to CNTRL group (Figure 1e, f ). Also, 
serum TG and cholesterol concentration were 
higher in T2DM mice (Figure 1g, h).
In order to assess insulin resistance, HOMA-
IR index, IPGTT and IPITT were performed. The 
data obtained here clearly demonstrate that 
T2DM mice were resistant to insulin, as showed 
by HOMA-IR index (Figure 1i) and by the AUC of 
both: IPGTT and IPITT (Figure 1j and k). 
Collectively, these results showed that the 
combination of HFD with two low doses of STZ 
promoted a detriment of the metabolic state 
including a discrete increment of body weight, 
higher FBG and insulin resistance, characteristic 
conditions of a T2DM.
T2DM did not promote renal damage
Since T2DM is associated with renal diseases, 
we analyzed classical kidney damage and 
renal function markers (Figure 2). Both, right 
and left kidney showed similar weight in both 
groups (Figure 2a, b) and there was no renal 
atrophy (measured by relative kidney weight 
related to body weight index) (Figure 2c, d). The 
measurement of blood creatinine levels showed 
a mild increase in the T2DM condition with 
respect to the CNTRL; though, such difference 
was statistically significant (Figure 2e). The BUN 
level presented no difference between the 
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Figure 1. Combination of HFD and 2 low doses of STZ reproduce the metabolic alterations of T2DM. (a) T2DM 
experimental model establishment (CNTRL: Control; HFD: High Fat Diet (45% fat); SC: Standard Chow (4.15% fat); 
STZ: Streptozotocin (40 mg/kg); T2DM: Type 2 Diabetes Mellitus), (b) Fasting blood glucose (FBG) levels (CNTRL n = 
15 mice and T2DM n = 21 mice), (c) Serum insulin concentration (CNTRL n = 8 mice and T2DM n = 6 mice), (d) Body 
weight (CNTRL n = 22 mice and T2DM n = 21 mice), (e) Retroperitoneal (CNTRL n = 6 mice and T2DM n = 10 mice) and 
(f) Epididymal fat (CNTRL n = 6 mice and T2DM n = 9 mice), Serum (g) Triglyceride (CNTRL n = 7 mice and T2DM n = 
7 mice) and (h) Cholesterol (CNTRL n = 7 mice and T2DM n = 7 mice) concentrations, (i) HOMA index (FBG x FI / 22.5) 
(CNTRL n = 8 mice and T2DM n = 6 mice) and intraperitoneal (j) glucose (CNTRL n = 9 mice and T2DM n = 9 mice) and 
(k) insulin (CNTRL n = 9 mice and T2DM n = 9 mice) tolerance tests with the respective area under the curve (AUC) 
graphs 6 weeks after dietary establishment and STZ injection.  Each dot represents individual values. ○: CNTRL 
mice; ●: T2DM mice. The results are shown as mean ± SEM. * p < 0.05; ** p < 0.001 and *** p < 0.0001 vs CNTRL.
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Figure 2. T2DM present no 
renal functional or structural 
damage. Measurement of 
(a) right (RK - (CNTRL n = 
8 and T2DM n = 11) and (b) 
left kidney (LK - (CNTRL n = 
8 and T2DM n = 11)) weight. 
Relationship of (c) RK (CNTRL 
n = 6 and T2DM n = 11) and (d) 
LK (CNTRL n = 6 and T2DM n = 
11) weight and body weight. 
(e) Blood creatinine (CNTRL 
n = 11 and T2DM n = 11) and 
(f) BUN (CNTRL n = 6 and 
T2DM n = 6) levels in T2DM 
and CNTRL animals. mRNA 
levels (n = 5 per group) of (g) 
KIM-1, (h) NGAL, (i) TIMP-2 
and (j) IGFBP7 in renal tissue 
expressed as RQ in respect to 
CNTRL group. Representative 
photomicrographies of kidney 
sections (Cortex): (k) Cortex 
from control mice – lack of 
NGAL immunostaining, (l) 
Cortical tubular epitelial cell 
from T2DM mice showing 
rare punctate NGAL staining 
(arrow). Bar: 50 μm. Each dot 
represents individual values. 
○: CNTRL mice; ●: T2DM mice. 
The results are shown as mean 
± SEM.
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groups (Figure 2f), indicating no alteration in the 
renal function in T2DM animals.
The mRNA levels of key markers associated 
with tissue damage were also assessed (Figure 
2g-j). KIM-1 and NGAL, markers of acute kidney 
damage, were not regulated by T2DM (Figure 2g, 
h). The NGAL gene expression results also were 
confirmed by immunofluorescence. Conversely 
to gene expression, the immunofluorescence 
depicted, even though that slightly, some 
NGAL expression, as showed in Figure 2k and l. 
As markers for kidney chronic diseases, TIMP-
2 and IGFBP7 that are associated with fibrosis 
and epithelial-to-mesenchymal transition 
process, were evaluated. T2DM animals did not 
present any difference in the mRNA levels when 
compared to the CNTRL group in both cases 
(Figure 2i, j). Together, these results indicate 
that during this period of analysis (6 weeks), 
the T2DM model developed here did not lead to 
kidney damage.
T2DM model induces changes in the immune 
response
It is widely accepted that T2DM induces a 
pro-inflammatory response, classically a non-
infectious disease (Spranger et al. 2003). Here we 
measure the circulating levels of three pivotal 
cytokines. Thus, the present T2DM mice model 
showed an increment of IL-1β and IL-6, without 
differences on the TNF-α levels (Figure 3a-c).
Collectively this data suggest that the T2DM 
mice model recapitulate the typical immune 
disorder induced in this disease.
T2DM decreases electron transport system 
oxygen consumption by mitochondrial content 
reduction
In several metabolic diseases where the 
cardiac function is impaired, the mitochondrial 
structure/function plays a vital role (Luptak et 
al. 2019). To analyse the mitochondrial function, 
we first performed a protocol with multiple 
substrates and inhibitors to measure oxygen 
flux consumed by mitochondria at different 
respiratory states. We also performed the 
measurement of H2O2 production to assess 
the electron leakage by the electron transport 
system (ETS) during non-phosphorylative 
respiratory state. The differences between 
the mitochondrial oxygen consumption from 
CNTRL and T2DM mice are shown in Figure 4. No 
significant difference in RCR, factor related to the 
oxidative phosphorylation coupling efficiency 
of ETS, was detected (Figure 4a). However, in all 
phosphorylative states (CIp, CIIp and OXPHOS), 
the cardiac mitochondria from T2DM mice 
presented reduced oxygen fluxes (22%, 13% and 
18%, respectively) when compared to CNTRL 
mice (Figure 4b-d). No significant changes were 
detected on LEAK, state related to non-specific 
protons leak (Figure 4e). 
The electron transport through the ETS 
favours electron leak in various sites of 
mitochondria generating superoxide, which is 
rapidly converted to H2O2. Thus, as showed in 
Figure 4f, significant decreased H2O2 production 
rates were observed in T2DM animals (27%) 
compared to CNTRL ones.
Citrate synthase (CS) is commonly used as 
quantitative marker of mitochondrial content 
(Mogensen et al. 2006). As observed in Figure 
4g, mitochondria from T2DM mice showed 
decreased CS activity (19%). 
Since the mitochondrial activity is highly 
associated to the mitochondrial content, we 
performed the normalization of respiratory 
fluxes of oxygen and H2O2 production by the 
CS activity. The normalized data showed in 
Figure 4h-l, strongly suggest that the changes 
observed were due to lower mitochondria 
content. In addition, in line with the CS activity, 
the protein content of mitochondrial complexes 
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Figure 3.  T2DM model induces changes in the immune response.  Serum (a) IL-1β, (b) IL-6 and (c) TNF-α cytokines 
concentration 6 weeks after treatment (CNTRL n = 8 mice and T2DM n = 8 mice). Each dot represents individual 
values. ○: CNTRL mice; ●: T2DM mice. The results are shown as mean ± SEM. * p < 0.05 and ** p < 0.001 vs CNTRL.
Figure 4. T2DM decreases oxygen flux and H2O2 production rate by reduction of mitochondrial content. (a) 
Respiratory control ratio (RCR), (b) oxygen flux in phosphorylative state with complex I linked substrates, (c) 
oxygen flux in phosphorylative state with complex II linked substrate, (d) maximal phosphorylative capacity 
of ETS, (e) non-specific leak of protons, (f) H2O2 production in non-phosphorylative state, (g) quantification of 
citrate synthase activity. (h, i, j, k and l) normalized data by the citrate synthase activity of graphs b, c, d, e and f, 
respectively (CNTRL n = 4 - 7 hearts and T2DM n = 6 - 8 hearts). Each dot represents independent mitochondrial 
isolation from one heart. ○: CNTRL mice; ●: T2DM mice. The results are shown as mean ± SEM. * p < 0.05 and ** p < 
0.001 vs CNTRL.
was drastically reduced between 12 to 37%, as 
demonstrated in Figure 5b-f.
The set of experiments performed depicts 
that T2DM mice model was able to decrease 
the mitochondrial content and consequently, 
decrease the cardiac mitochondrial performance.
DISCUSSION
Although approximately 90% of the diabetic 
patients develop T2DM (Zheng et al. 2018), 
most of the experimental works to study the 
mechanism of the cardiac damage induced 
by this disease have been performed in T1DM 
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animal models (Casis et al. 2000, Torres-
Jacome et al. 2013), demonstrating the lack of a 
suitable T2DM animal model. Therefore, the data 
obtained here allow us to propose a new T2DM 
mice model that mimics the natural history of 
this syndrome in humans to deepen study the 
metabolic and cardiac characteristics. 
Previous studies have reported the use of 
the combination of a high fat diet (HFD) and 
low dose of streptozotocin (STZ) to induce T2DM 
in experimental animal models (Srinivasan & 
Ramarao 2007, Reed et al. 2000, Li et al. 2015). 
Nevertheless, there are still methodology 
variations concerning to dietary administration 
period prior to STZ injection and, overall, to the 
administered STZ dose (Srinivasan & Ramarao 
2007, Reed et al. 2000). In the present study, 
we successfully obtained a T2DM mice model 
which mimics an end stage of the human T2DM, 
obtained in a short period of time. 
Usually, T2DM mice models are associated 
to obesity derived from metabolic syndrome 
(Srinivsan et al. 2005). Here, despite HFD feeding, 
T2DM mice have not shown an exacerbated body 
weight gain, but present higher visceral fat mass 
percentage when compared to CNTRL group, 
as it is described to non-obese T2DM patients 
(Vaag & Lund 2007). 
It is well described that T2DM patients, in 
advanced stages of the disease develop several 
problems such as cardiovascular complications, 
microangiopathy, retinopathy, neuropathy or 
nephropathy. Indeed, T2DM is the leading cause of 
end stage renal disease, which increases the risk 
of death among patients with diabetes (Brancati 
et al. 1997, Finne et al. 2019). Wu et al. (2010) in a 
Figure 5. T2DM depicts lower cardiac mitochondria complexes. (a) Western-blott assay and the representative 
graphs of protein content of mitochondrial (b) Complex I, (c) Complex II, (d) Complex III, (e) Complex IV and (f) 
Complex V. Each dot represents independent mitochondrial isolation. ○: CNTRL mice; ●: T2DM mice. CNTRL n = 7 
hearts and T2DM n = 6 - 7 hearts. The results are shown as mean ± SEM. * p < 0.05 and ** p < 0.001 vs CNTRL. Each 
symbol represents an independent mitochondria preparation from one heart. 
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T2DM aging mice showed that renal impairment 
was due in part to the excessive stress and 
inflammation derived from the aging process 
and that diabetes may accelerate the underlying 
kidney aging process present in old mice (Wu et 
al. 2010). When we evaluate renal morphology 
and function through kidney damage markers 
and biochemical measurements, no renal 
functional or tissue damage was observed, even 
though slightly NGAL expression was observed, 
which lead us to propose that our T2DM model, 
at least in 6 weeks, would not present a typical 
chronic stage of the T2DM disease.
In the last decade the study of the role of 
inflammatory responses in the physiopathology 
of T2DM has increased (Herder et al. 2015). 
Several works described that IL-1β contribute not 
only to impair the β-cell function (Maedler et al. 
2002) but also cardiac function (Monnerat et al. 
2016, Fernández-Sada et al. 2017). In this regards, 
different clinical trials are actually ongoing in 
order to understand the potential therapeutic 
role of this cytokine (Zhao et al. 2014). In this 
sense, we observed an increase of IL-1β and IL-6 
in T2DM mice. This could lead us to think that 
these cytokines may play an essential role in 
the pathophysiology of this disease that needs 
to be studied in depth.
Furthermore, it is well described that 
metabolic disturbance is a typical finding in T2DM 
(Wang et al. 2010). In this regards, mitochondrial 
dysfunction can play a critical role in the 
development of T2DM related disturbances. 
However, if the energetic deficit of cardiac tissue 
is due to insufficient or to defective mitochondrial 
function, which can play a pathogenic role on 
T2DM (Szendroedi et al. 2011) is yet a debate. 
Koncsos et al. (2016) described, in a prediabetes 
state, that early changes in several phenomena 
such as changes in cardiac mitophagy and 
elevated subsarcolemmal mitochondria reactive 
oxygen species production may be responsible 
for prediabetic cardiac complications. This leads 
us to propose that in a diabetic state, these 
phenomena still persist (Koncsos et al. 2016). Our 
measurements showed that T2DM mitochondrial 
H2O2 released is lower when compared to CTRL, 
but correlates with the decreased levels (less 
20-30%) in mitochondrial content (Figure 4). This 
apparent contradiction is explained by the fact 
that: 1- The work performed by Koncsos et al. 
(2016) evaluated mitochondrial H2O2 in a pre-
diabetic state; 2- in that study it was used the 
subsarcolemmal preparations of mitochondria; 
and finally 3- in this previous study the high H2O2 
released from mitochondria was only observed 
in the presence of CI-linked substrates.
Concurrent with this, here we observed that 
the lower mitochondria response was due to 
lower mitochondrial content and complex of 
ETS abundance, as showed by citrate synthase 
activity and the Western-blotting assay (Figures 
4-5). These results allow us to suggest that 
the impairment on cardiac mitochondrial 
function observed in the T2DM model, was due 
to lower mitochondrial content and not to a 
specific mitochondrial dysfunction attributable 
to altered mitochondria function. A similar 
observation was seen in skeletal human 
permeabilized muscle fibers from biopsies of 
the quadriceps of T2DM patients, in which no 
mitochondrial dysfunction, but lower content 
was detected (Boushel et al. 2007). In line with 
our results, Marciniak et al. (2014) found that 
mice fed with HFD that received or not STZ 
was associated with a dramatic reduction in 
mitochondrial respiration (Marciniak et al. 2014). 
Other recent study (Croston et al. 2014) with T2DM 
in human cardiac biopsies showed decreased 
oxidative phosphorylation function and CI and 
CIV complex levels specifically subsarcolemmal 
mitochondria.  
In summary, the results showed here 
demonstrate that in this non-obese T2DM model 
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cardiac mitochondrial function is impaired as a 
consequence of lower mitochondrial content, 
recapitulating the mitochondrial impairment 
previously described in human skeletal muscle 
obtained from T2DM patients. Therefore, this 
T2DM mice model emerge as a great tool for 
deepen study the mechanisms underlying these 
alterations and allows future investigations 
of the molecular energetic basis of diabetes 
disease.
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